Resources from the same session
Can we stop targeted therapy, immune therapy?
Presenter: V. Grünwald, DE
Session: SESSION 6 - Focus on toxicity and duration of therapy
Resources:
Slides
Webcast
All you need to know on FGR inhibitor toxicity management
Presenter: P. Giannatempo, IT
Session: SESSION 6 - Focus on toxicity and duration of therapy
Resources:
Slides
Webcast
Participants clinical case discussion: Severe aplastic anemia following dual immunotherapy in patient with mRCC - case report
Presenter: A. Dakovic, HR
Session: SESSION 6 - Focus on toxicity and duration of therapy
Resources:
Slides
Webcast
Participants clinical case discussion: Immune-Related Myasthenia Gravis: A Rare but Severe Adverse Event in Clear Cell Renal Carcinoma Therapy
Presenter: D. Leite Russo, PT
Session: SESSION 6 - Focus on toxicity and duration of therapy
Resources:
Slides
Webcast